Know How Meds for Postmenopausal Osteoporosis Stack Up

October 2020

The plethora of med options will raise questions about how to treat postmenopausal osteoporosis...especially with conflicting guidelines.

Which med should be used first? Stick with oral alendronate for most patients. It’s about $60/year...versus $1,700 for risedronate.

If patients can’t take an oral bisphosphonate, try once-yearly IV zoledronic acid (Reclast). It’s about $270/year plus infusion costs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote